Literature DB >> 7491768

Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm.

R Stauber1, G A Gaitanaris, G N Pavlakis.   

Abstract

Expression of gag/pol and env genes of human immunodeficiency virus requires the viral Rev protein. Mutant Rev proteins, displaying a transdominant phenotype (TDRev), were shown to inhibit Rev function. To investigate the underlying mechanism of this inhibition, the green fluorescent protein (GFP) of Aequorea victoria was fused to Rev and TDRev, which allowed the study of their trafficking and interactions in living human cells. Both Rev-GFP and TDRev-GFP were shown to retain appropriate nucleolar localization and function. Upon actinomycin D treatment, Rev-GFP was transported to the cytoplasm within 1.5 hr, while TDRev, although partially dissociated from the nucleolus, was retained in the nucleus. Coexpression of Rev-GFP and TDRev in the same cell demonstrated that TDRev inhibited the transport of Rev-GFP from the nucleus to the cytoplasm. This inhibition was specific for Rev, since the export of the functionally analogous Rex protein of the human T-cell leukemia virus type I was not inhibited by TDRev. These results indicate that Rev and TDRev form heteromultimers in the nucleolus and that this interaction prevents Rev's export from the nucleus to the cytoplasm. In addition to providing a model for the function of TDRev, these results also demonstrate the successful application of protein fusions to GFP to study localization and trafficking of proteins in living mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491768     DOI: 10.1006/viro.1995.0016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  The adenovirus type 5 E1B-55K oncoprotein actively shuttles in virus-infected cells, whereas transport of E4orf6 is mediated by a CRM1-independent mechanism.

Authors:  T Dosch; F Horn; G Schneider; F Krätzer; T Dobner; J Hauber; R H Stauber
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  A nucleolar TAR decoy inhibitor of HIV-1 replication.

Authors:  Alessandro Michienzi; Shirley Li; John A Zaia; John J Rossi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-10       Impact factor: 11.205

3.  Requirements for mouse mammary tumor virus Rem signal peptide processing and function.

Authors:  Hyewon Byun; Nimita Halani; Yongqiang Gou; Andrea K Nash; Mary M Lozano; Jaquelin P Dudley
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

4.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Characterization of the bipartite nuclear localization signal of protein LANA2 from Kaposi's sarcoma-associated herpesvirus.

Authors:  Cesar Muñoz-Fontela; Estefanía Rodríguez; Cesar Nombela; Javier Arroyo; Carmen Rivas
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

6.  A novel set of nuclear localization signals determine distributions of the alphaCP RNA-binding proteins.

Authors:  Alexander N Chkheidze; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

7.  Identification of novel import and export signals of human TAP, the protein that binds to the constitutive transport element of the type D retrovirus mRNAs.

Authors:  J Bear; W Tan; A S Zolotukhin; C Tabernero; E A Hudson; B K Felber
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

8.  Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.

Authors:  S Lee; M Neumann; R Stearman; R Stauber; A Pause; G N Pavlakis; R D Klausner
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

9.  Role of polypyrimidine tract binding protein in the function of the hepatitis B virus posttranscriptional regulatory element.

Authors:  W Q Zang; B Li; P Y Huang; M M Lai; T S Yen
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 10.  Taspase1: a 'misunderstood' protease with translational cancer relevance.

Authors:  D Wünsch; A Hahlbrock; S Jung; T Schirmeister; J van den Boom; O Schilling; S K Knauer; R H Stauber
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.